These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26752643)

  • 1. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.
    Halper-Stromberg A; Nussenzweig MC
    J Clin Invest; 2016 Feb; 126(2):415-23. PubMed ID: 26752643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.
    Zhang Z; Li S; Gu Y; Xia N
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment.
    Gama L; Koup RA
    Annu Rev Med; 2018 Jan; 69():409-419. PubMed ID: 29029583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission?
    Ananworanich J; McSteen B; Robb ML
    Curr Opin HIV AIDS; 2015 May; 10(3):198-206. PubMed ID: 25700203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.
    Thavarajah JJ; Hønge BL; Wejse CM
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.
    Parsons MS; Chung AW; Kent SJ
    Retrovirology; 2018 Aug; 15(1):58. PubMed ID: 30134945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.
    Caskey M; Klein F; Nussenzweig MC
    Nat Med; 2019 Apr; 25(4):547-553. PubMed ID: 30936546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody B cell responses in HIV-1 infection.
    Mouquet H
    Trends Immunol; 2014 Nov; 35(11):549-61. PubMed ID: 25240985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection.
    Cohen YZ; Caskey M
    Curr Opin HIV AIDS; 2018 Jul; 13(4):366-373. PubMed ID: 29697469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Neutralizing Antibodies: Magic Bullets against HIV?
    Julg B; Alter G
    Immunity; 2016 Jun; 44(6):1253-4. PubMed ID: 27332729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.
    Lin A; Balazs AB
    Retrovirology; 2018 Oct; 15(1):66. PubMed ID: 30285769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing immunotherapy towards achieving a functional cure for HIV-1.
    Sugiyama FHC; Dietz LL; Søgaard OS
    Curr Opin HIV AIDS; 2024 Jul; 19(4):187-193. PubMed ID: 38686856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering broadly neutralizing antibodies for HIV prevention and therapy.
    Hua CK; Ackerman ME
    Adv Drug Deliv Rev; 2016 Aug; 103():157-173. PubMed ID: 26827912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.
    Nishimura Y; Martin MA
    Cell Host Microbe; 2017 Aug; 22(2):207-216. PubMed ID: 28799906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo protection by broadly neutralizing HIV antibodies.
    van Gils MJ; Sanders RW
    Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    Mahomed S; Garrett N; Baxter C; Abdool Karim Q; Abdool Karim SS
    J Infect Dis; 2021 Feb; 223(3):370-380. PubMed ID: 32604408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly neutralizing antibodies targeting HIV: Progress and challenges.
    Paneerselvam N; Khan A; Lawson BR
    Clin Immunol; 2023 Dec; 257():109809. PubMed ID: 37852345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies.
    Carrillo J; Clotet B; Blanco J
    Front Immunol; 2018; 9():2429. PubMed ID: 30405624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of broadly neutralizing antibodies for HIV-1 prevention.
    Pegu A; Hessell AJ; Mascola JR; Haigwood NL
    Immunol Rev; 2017 Jan; 275(1):296-312. PubMed ID: 28133803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality.
    Waters L; de Miguel-Buckley R; Poulin S; Arribas JR
    Clin Infect Dis; 2023 Mar; 76(6):1136-1141. PubMed ID: 36303321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.